PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.48M | 34.15M | 44.62M | 43.61M | 17.32M |
| Total Receivables | 7.59M | 8.50M | 12.01M | 11.74M | 5.91M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 374.70K | 419.80K | 496.40K | 485.10K | 214.30K |
| Total Current Assets | 38.45M | 43.07M | 57.12M | 55.83M | 23.45M |
|
|
|||||
| Total Current Assets | 38.45M | 43.07M | 57.12M | 55.83M | 23.45M |
| Net Property, Plant & Equipment | 1.33M | 1.49M | 1.05M | 1.03M | 823.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.44M | 2.74M | 2.70M | 2.64M | 2.83M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 42.22M | 47.30M | 60.87M | 59.50M | 27.10M |
|
|
|||||
| Total Accounts Payable | 6.14M | 6.88M | 5.02M | 4.91M | 5.05M |
| Total Accrued Expenses | 664.80K | 744.80K | 843.60K | 824.50K | 612.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 236.20K | 264.70K | 206.70K | 202.00K | 221.10K |
| Total Finance Division Other Current Liabilities | -- | -- | 4.20K | 4.10K | -- |
| Total Other Current Liabilities | -- | -- | 4.20K | 4.10K | -- |
| Total Current Liabilities | 7.04M | 7.89M | 6.08M | 5.94M | 5.88M |
|
|
|||||
| Total Current Liabilities | 7.04M | 7.89M | 6.08M | 5.94M | 5.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 511.80K | 573.40K | 535.80K | 523.60K | 149.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 196.80K | 220.50K | 182.80K | 178.60K | 150.90K |
| Total Liabilities | 7.75M | 8.68M | 6.79M | 6.64M | 6.18M |
|
|
|||||
| Common Stock & APIC | 142.69M | 159.87M | 153.84M | 150.36M | 107.35M |
| Retained Earnings | -112.30M | -125.82M | -104.01M | -101.66M | -90.84M |
| Treasury Stock & Other | 3.92M | 4.39M | 3.88M | 3.79M | 3.87M |
| Total Common Equity | 34.31M | 38.44M | 53.71M | 52.49M | 20.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.31M | 38.44M | 53.71M | 52.49M | 20.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 164.40K | 184.20K | 373.00K | 364.60K | 533.40K |
| Total Equity | 34.47M | 38.62M | 54.08M | 52.86M | 20.92M |
|
|
|||||